These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells. Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and characterization of a cell-permeable bimodal contrast agent targeting β-galactosidase. Keliris A; Ziegler T; Mishra R; Pohmann R; Sauer MG; Ugurbil K; Engelmann J Bioorg Med Chem; 2011 Apr; 19(8):2529-40. PubMed ID: 21459584 [TBL] [Abstract][Full Text] [Related]
6. Peptide-conjugated polyamidoamine dendrimer as a nanoscale tumor-targeted T1 magnetic resonance imaging contrast agent. Han L; Li J; Huang S; Huang R; Liu S; Hu X; Yi P; Shan D; Wang X; Lei H; Jiang C Biomaterials; 2011 Apr; 32(11):2989-98. PubMed ID: 21277017 [TBL] [Abstract][Full Text] [Related]
7. Phosphinic derivative of DTPA conjugated to a G5 PAMAM dendrimer: an 17O and 1H relaxation study of its Gd(III) complex. Lebdusková P; Sour A; Helm L; Tóth E; Kotek J; Lukes I; Merbach AE Dalton Trans; 2006 Jul; (28):3399-406. PubMed ID: 16832488 [TBL] [Abstract][Full Text] [Related]
8. Highly selective luminescent nanostructures for mitochondrial imaging and targeting. Fanizza E; Iacobazzi RM; Laquintana V; Valente G; Caliandro G; Striccoli M; Agostiano A; Cutrignelli A; Lopedota A; Curri ML; Franco M; Depalo N; Denora N Nanoscale; 2016 Feb; 8(6):3350-61. PubMed ID: 26763470 [TBL] [Abstract][Full Text] [Related]
9. Effect of the Conjugation Density of Triphenylphosphonium Cation on the Mitochondrial Targeting of Poly(amidoamine) Dendrimers. Bielski ER; Zhong Q; Brown M; da Rocha SR Mol Pharm; 2015 Aug; 12(8):3043-53. PubMed ID: 26158804 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and Characterization of a Biotinylated Multivalent Targeted Contrast Agent. Gündüz S; Power A; Maier ME; Logothetis NK; Angelovski G Chempluschem; 2015 Mar; 80(3):612-622. PubMed ID: 31973412 [TBL] [Abstract][Full Text] [Related]
11. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action. Caravan P Acc Chem Res; 2009 Jul; 42(7):851-62. PubMed ID: 19222207 [TBL] [Abstract][Full Text] [Related]
12. Exploration of the impact of stereochemistry on the identification of the novel translocator protein PET imaging agent [(18)F]GE-180. Chau WF; Black AM; Clarke A; Durrant C; Gausemel I; Khan I; Mantzilas D; Oulie I; Rogstad A; Trigg W; Jones PA Nucl Med Biol; 2015 Sep; 42(9):711-9. PubMed ID: 26072270 [TBL] [Abstract][Full Text] [Related]
13. A positron emission tomography image-guidable unimolecular micelle nanoplatform for cancer theranostic applications. Yang J; Lu W; Xiao J; Zong Q; Xu H; Yin Y; Hong H; Xu W Acta Biomater; 2018 Oct; 79():306-316. PubMed ID: 30172067 [TBL] [Abstract][Full Text] [Related]
14. Preparation and preliminary evaluation of a biotin-targeted, lectin-targeted dendrimer-based probe for dual-modality magnetic resonance and fluorescence imaging. Xu H; Regino CA; Koyama Y; Hama Y; Gunn AJ; Bernardo M; Kobayashi H; Choyke PL; Brechbiel MW Bioconjug Chem; 2007; 18(5):1474-82. PubMed ID: 17711320 [TBL] [Abstract][Full Text] [Related]
16. Bridging Pharmaceutical Chemistry with Drug and Nanoparticle Targeting to Investigate the Role of the 18-kDa Translocator Protein TSPO. Iacobazzi RM; Lopalco A; Cutrignelli A; Laquintana V; Lopedota A; Franco M; Denora N ChemMedChem; 2017 Aug; 12(16):1261-1274. PubMed ID: 28771957 [TBL] [Abstract][Full Text] [Related]
18. Plasmid pORF-hTRAIL targeting to glioma using transferrin-modified polyamidoamine dendrimer. Gao S; Li J; Jiang C; Hong B; Hao B Drug Des Devel Ther; 2016; 10():1-11. PubMed ID: 26719669 [TBL] [Abstract][Full Text] [Related]
19. Wei X; Liu Z; Zhao Z Hell J Nucl Med; 2019; 22(1):78-79. PubMed ID: 30968863 [TBL] [Abstract][Full Text] [Related]